MRx0518
MRx0518-I-002
Phase 2 small_molecule terminated
Quick answer
MRx0518 for Oncology is a Phase 2 program (small_molecule) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Oncology
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated